S'abonner

Management of sarcoma recurrence after megaprosthesis of the knee - 12/06/22

Doi : 10.1016/j.otsr.2022.103276 
Grégoire Rougereau a, , Frédérique Larousserie b, Philippe Anract a, David Biau a
a Département d’orthopédie et traumatologie, hôpital Cochin, AP–HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France 
b Département d’anatomopathologie, hôpital Cochin, AP–HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

The management of local sarcoma recurrence about the knee (at the distal femur or proximal tibia) is challenging. The objective of this study was to describe the locations of local sarcoma recurrences about knee megaprostheses, the treatments used for each type of recurrence, and the outcomes according to the treatment used.

Hypothesis

The strategy for treating a local sarcoma recurrence about the knee must be based on the topography of tumour involvement.

Materials and methods

We included 13 patients who had local sarcoma recurrence about a knee megaprosthesis and were followed up for at least 2 years. The diagnosis was osteosarcoma in 10 patients and chondrosarcoma in 3 patients. The distal femur was involved in 11 patients and the proximal tibia in 2 patients. We classified the patients into two groups based on whether the tumour involved important structures or was at a distance within the soft tissues.

Results

The recurrence was a nodule at a distance of important structures in 8 (57%) patients, in whom the mean time to recurrence was 15 months (range, 2–34 months). The remaining 5 (38.5%) patients had involvement of important structures in the popliteal fossa and a mean time to recurrence of 42 months (range, 16–80 months). Surgery was performed in 10 patients; the other 3 patients received palliative care due to rapid metastatic dissemination. Of the 6 patients who had surgery for a recurrence at a distance from important structures, 5 (83.3%) underwent isolated tumour resection with the goal of salvaging the limb and 1 (16.7%) underwent transfemoral amputation. Transfemoral amputation was performed in all 3 patients who had surgery for popliteal recurrences. Lung metastases were detected in 10 (77%) patients, 2 at the time of initial sarcoma diagnosis and 8 at the time of the local recurrence. At last follow-up, 5 patients were alive, including 2 (33.3%) of the 6 patients with recurrences at a distance from important structures and all 3 patients with popliteal recurrences. Of the 5 survivors at last follow-up, 2 had metastases.

Conclusion

In patients with local recurrence of knee sarcoma, three presentations can be distinguished. When the local recurrence coincides with distant recurrence, failure to control the disease is likely and the local treatment should be designed as a component of palliative care. When no metastases are detected but the local recurrence is in contact with important structures, amputation is advisable at present given the complexity of limb-salvage surgery and high risk of further local recurrence. Finally, when no metastases are detected and the local recurrence is at a distance from important structures, limb-salvage surgery deserves consideration.

Level of evidence

IV, retrospective observational study.

Le texte complet de cet article est disponible en PDF.

Keywords : Osteosarcoma, Chondrosarcoma, Local recurrence, Knee replacement for tumor


Plan


© 2022  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 108 - N° 4

Article 103276- juin 2022 Retour au numéro
Article précédent Article précédent
  • Does the adherence of distal femur parosteal osteosarcoma to the neurovascular bundle increase the rate of local recurrences?
  • Khodamorad Jamshidi, Alireza Mirzaei, Abolfazl Bagherifard, Ali Jahansouz, Mahmoud Reza Mohaghegh
| Article suivant Article suivant
  • Analysis of mechanical complications for patients with extremity sarcoma after biological reconstruction
  • Jun Wang, Zhiye Du, Rongli Yang, Xiaodong Tang, Wei Guo

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.